Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy.
Franzetti M, Adorni F, Oreni L, Van Den Bogaart L, Resnati C, Milazzo L, Antinori S, Galli M, Ridolfo AL. Franzetti M, et al. Among authors: resnati c. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):493-8. doi: 10.1097/QAI.0000000000000347. J Acquir Immune Defic Syndr. 2014. PMID: 25230291
Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice.
Cattaneo D, Baldelli S, Resnati C, Giacomelli A, Meraviglia P, Minisci D, Astuti N, Ridolfo A, De Socio GV, Clementi E, Galli M, Gervasoni C. Cattaneo D, et al. Among authors: resnati c. World J Biol Psychiatry. 2020 Oct;21(8):651-657. doi: 10.1080/15622975.2018.1500032. Epub 2018 Sep 20. World J Biol Psychiatry. 2020. PMID: 30058430
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study.
Cattaneo D, Cossu MV, Fucile S, Riva A, Baldelli S, Meraviglia P, Landonio S, Impagnatiello C, Resnati C, Galli M, Clementi E, Capetti A, Rizzardini G, Gervasoni C. Cattaneo D, et al. Among authors: resnati c. Ther Drug Monit. 2015 Feb;37(1):119-25. doi: 10.1097/FTD.0000000000000114. Ther Drug Monit. 2015. PMID: 24988438 Clinical Trial.
Abacavir-induced liver toxicity.
Pezzani MD, Resnati C, Di Cristo V, Riva A, Gervasoni C. Pezzani MD, et al. Among authors: resnati c. Braz J Infect Dis. 2016 Sep-Oct;20(5):502-4. doi: 10.1016/j.bjid.2016.03.002. Epub 2016 Apr 4. Braz J Infect Dis. 2016. PMID: 27054757 Free PMC article. Review.
Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals.
Peters L, Laut K, Resnati C, Del Campo S, Leen C, Falconer K, Trofimova T, Paduta D, Gatell J, Rauch A, Lacombe K, Domingo P, Chkhartishvili N, Zangerle R, Matulionyte R, Mitsura V, Benfield T, Zilmer K, Khromova I, Lundgren J, Rockstroh J, Mocroft A; EuroSIDA Study Group. Peters L, et al. Among authors: resnati c. AIDS. 2018 Sep 10;32(14):1995-2004. doi: 10.1097/QAD.0000000000001928. AIDS. 2018. PMID: 29912062 Free article.
23 results